Zobrazeno 1 - 10
of 21 123
pro vyhledávání: '"bispecific"'
Autor:
Xie Z; Institute of Virology, School of Medicine and Health, Technical University of Munich / Helmholtz Munich, Germany., Protzer U; Institute of Virology, School of Medicine and Health, Technical University of Munich / Helmholtz Munich, Germany; German Center for Infection Research (DZIF), Munich Partner Sites, Germany. Electronic address: protzer@tum.de.
Publikováno v:
Antiviral research [Antiviral Res] 2024 Sep; Vol. 229, pp. 105972. Date of Electronic Publication: 2024 Jul 30.
Autor:
Kim TM; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea. Electronic address: gabriel9@snu.ac.kr., Taszner M; Department of Haematology and Transplantology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland., Novelli S; Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Cho SG; Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea., Villasboas JC; Mayo Clinic, Rochester, USA., Merli M; Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Jiménez-Ubieto A; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Tessoulin B; Hematology Department, Nantes University Hospital, Nantes, France., Poon LM; Hematology Oncology National University Hospital, Singapore, Singapore., Tucker D; Department of Hematology, Royal Cornwall Hospital, Truro, UK., Walewski J; Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Warsaw, Poland., Yi S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China., Song Y; Department of Lymphoma, Peking University Cancer Hospital & Institute (Beijing Cancer Hospital), Beijing, China., Chong G; Department of Medical Oncology, and Clinical Haematology, Olivia Newton-John Cancer Centre, Heidelberg, Australia., Bachy E; Department of Hematology, Lyon Sud Hospital, Lyon, France; Lymphoma Immuno-Biology (LIB) team, Inserm U1111, CIRI, Lyon, France., Guidez S; Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers, France., Alonso A; Hospital Universitario Quiron Salud Madrid, Madrid, Spain., Jagadeesh D; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, USA., Zhang W; Hematology Department, Peking Union Medical College Hospital, Beijing, China., Magnano L; Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Iskierka-Jażdżewska E; Copernicus Memorial Hospital, Department of General Hematology, Medical University of Łódź, Łódź, Poland., Tani M; Hematology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy., Shen B; Regeneron Pharmaceuticals, Inc., Tarrytown, USA., Uppala A; Regeneron Pharmaceuticals, Inc., Tarrytown, USA., Zhu M; Regeneron Pharmaceuticals, Inc., Tarrytown, USA., Shariff S; Regeneron UK Ltd., Uxbridge, UK., Brouwer-Visser J; Regeneron Pharmaceuticals, Inc., Tarrytown, USA., Chaudhry A; Regeneron Pharmaceuticals, Inc., Tarrytown, USA., Mohamed H; Regeneron Pharmaceuticals, Inc., Tarrytown, USA., Ambati S; Regeneron Pharmaceuticals, Inc., Tarrytown, USA., Luminari S; Division of Hematology, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Nov; Vol. 35 (11), pp. 1039-1047. Date of Electronic Publication: 2024 Aug 13.
Autor:
Osuna M; Department of Pediatrics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan., Nakajima Y; Department of Pediatrics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan. nakajima-yamanashi@naramed-u.ac.jp.; Advanced Medical Science of Thrombosis and Hemostasis, Nara Medical University, Kashihara, Japan. nakajima-yamanashi@naramed-u.ac.jp., Ogiwara K; Department of Pediatrics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan., Nogami K; Department of Pediatrics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.
Publikováno v:
International journal of hematology [Int J Hematol] 2024 Nov; Vol. 120 (5), pp. 639-644. Date of Electronic Publication: 2024 Aug 07.
Autor:
Xu S; Department of Environment and Genetics, School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, Australia. Shilian.Xu@latrobe.edu.au.; Department of Mathematical and Physical Science, La Trobe University, Bundoora, Australia. Shilian.Xu@latrobe.edu.au.
Publikováno v:
Scientific reports [Sci Rep] 2024 Oct 26; Vol. 14 (1), pp. 25557. Date of Electronic Publication: 2024 Oct 26.
Autor:
Jiang Q; Department of Periodontics and Oral Medicine, College of Stomatology, Guangxi Medical University, Nanning, P. R. China.; Guangxi Health Commission Key Laboratory of Prevention and Treatment for Oral Infectious Diseases, Nanning, P. R. China.; Guangxi Key Laboratory of Oral and Maxillofacial Rehabilitation and Reconstruction, Guangxi Universities and Colleges Key Laboratory of Oral and Maxillofacial Surgery Disease Treatment, Guangxi Clinical Research Center for Craniofacial Deformity, Nanning, Guangxi, P. R. China., Chen X; Department of Periodontics and Oral Medicine, College of Stomatology, Guangxi Medical University, Nanning, P. R. China.; Guangxi Health Commission Key Laboratory of Prevention and Treatment for Oral Infectious Diseases, Nanning, P. R. China.; Guangxi Key Laboratory of Oral and Maxillofacial Rehabilitation and Reconstruction, Guangxi Universities and Colleges Key Laboratory of Oral and Maxillofacial Surgery Disease Treatment, Guangxi Clinical Research Center for Craniofacial Deformity, Nanning, Guangxi, P. R. China., Wu J; Department of Periodontics and Oral Medicine, College of Stomatology, Guangxi Medical University, Nanning, P. R. China.; Guangxi Health Commission Key Laboratory of Prevention and Treatment for Oral Infectious Diseases, Nanning, P. R. China.; Guangxi Key Laboratory of Oral and Maxillofacial Rehabilitation and Reconstruction, Guangxi Universities and Colleges Key Laboratory of Oral and Maxillofacial Surgery Disease Treatment, Guangxi Clinical Research Center for Craniofacial Deformity, Nanning, Guangxi, P. R. China., Wei S; Department of Periodontics and Oral Medicine, College of Stomatology, Guangxi Medical University, Nanning, P. R. China.; Guangxi Health Commission Key Laboratory of Prevention and Treatment for Oral Infectious Diseases, Nanning, P. R. China.; Guangxi Key Laboratory of Oral and Maxillofacial Rehabilitation and Reconstruction, Guangxi Universities and Colleges Key Laboratory of Oral and Maxillofacial Surgery Disease Treatment, Guangxi Clinical Research Center for Craniofacial Deformity, Nanning, Guangxi, P. R. China., Tao R; Department of Periodontics and Oral Medicine, College of Stomatology, Guangxi Medical University, Nanning, P. R. China. taorenchuan@gxmu.edu.cn.; Guangxi Health Commission Key Laboratory of Prevention and Treatment for Oral Infectious Diseases, Nanning, P. R. China. taorenchuan@gxmu.edu.cn.; Guangxi Key Laboratory of Oral and Maxillofacial Rehabilitation and Reconstruction, Guangxi Universities and Colleges Key Laboratory of Oral and Maxillofacial Surgery Disease Treatment, Guangxi Clinical Research Center for Craniofacial Deformity, Nanning, Guangxi, P. R. China. taorenchuan@gxmu.edu.cn.
Publikováno v:
BMC oral health [BMC Oral Health] 2024 Oct 18; Vol. 24 (1), pp. 1240. Date of Electronic Publication: 2024 Oct 18.
Autor:
Moirangthem R; Department of Immunology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3525422, Israel., Cordela S; Department of Immunology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3525422, Israel., Khateeb D; Department of Immunology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3525422, Israel., Shor B; School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem 9190501, Israel., Kosik I; Cellular Biology Section, Laboratory of Viral Diseases, NIAID, Bethesda, MD 20892, USA., Schneidman-Duhovny D; School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem 9190501, Israel., Mandelboim M; Central Virology Laboratory, Sheba Medical Center, Tel Hashomer 52621, Israel., Jönsson F; Institut Pasteur, Université de Paris, Unit of Antibodies in Therapy and Pathology; Inserm UMR1222, Paris 75015, France; CNRS, Paris 75015, France., Yewdell JW; Cellular Biology Section, Laboratory of Viral Diseases, NIAID, Bethesda, MD 20892, USA., Bruel T; Virus and Immunity Unit, Institut Pasteur, Université Paris Cité; CNRS UMR3569, Paris, France; Vaccine Research Institute, Créteil, France., Bar-On Y; Department of Immunology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3525422, Israel. Electronic address: ybaron@technion.ac.il.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Oct 02; Vol. 32 (10), pp. 3712-3728. Date of Electronic Publication: 2024 Jul 31.
Autor:
Saito S; Molecular Analysis Center, R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan., Nakayama M; Research Core Function Laboratories, R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan., Yamazaki K; Molecular Analysis Center, R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan., Miyamoto Y; Molecular Analysis Center, R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan., Hiraishi K; Molecular Analysis Center, R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan., Tomioka D; Molecular Analysis Center, R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan., Takagi-Maeda S; Modality Research Laboratories, R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan., Usami K; Modality Research Laboratories, R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan., Takahashi N; R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan., Nara S; Molecular Analysis Center, R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan., Imai E; Molecular Analysis Center, R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan.
Publikováno v:
Protein science : a publication of the Protein Society [Protein Sci] 2024 Oct; Vol. 33 (10), pp. e5121.
Autor:
Herrera M; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada., Pretelli G; Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Desai J; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Garralda E; Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada., Steiner TM; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Au L; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Electronic address: Lewis.au@petermac.org.
Publikováno v:
Trends in cancer [Trends Cancer] 2024 Oct; Vol. 10 (10), pp. 893-919. Date of Electronic Publication: 2024 Aug 30.
Autor:
Chari A; Department of Medicine, Hematology, and Medical Oncology and Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY. Electronic address: ajai.chari@ucsf.edu., Krishnan A; Judy and Bernard Briskin Myeloma Center, City of Hope Comprehensive Cancer Center, Duarte, CA., Rasche L; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany., Ye JC; Department of Lymphoma - Myeloma, Division of Cancer Medicine, MD Anderson Cancer Center, University of Texas, Houston, TX., Garfall A; Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Popat R; Hematology Department, University College London Hospitals NHS Foundation Trust, London, UK., Lipe B; Department of Medicine, University of Rochester Medical Center, Rochester, NY., Qin X; Janssen Research and Development, Spring House, PA., Campagna M; Janssen Research and Development, Madrid, Spain., Masterson T; Janssen Research and Development, Spring House, PA., Tomlinson C; Janssen Research and Development, Raritan, NJ., Hilder B; Janssen Research and Development, Spring House, PA., Tolbert J; Janssen Research and Development, Spring House, PA., Renaud T; Janssen Research and Development, Raritan, NJ., Smit MD; Janssen Biologics B.V., Leiden, The Netherlands., Gray K; Janssen Scientific Affairs, Horsham, PA., Kane C; Janssen Research and Development, Spring House, PA., Heuck C; Janssen Research and Development, Spring House, PA., van de Donk NWCJ; Department of Hematology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Oct; Vol. 24 (10), pp. 665-693.e14. Date of Electronic Publication: 2024 May 15.
Autor:
Wu G; National Institutes for Food and Drug Control, State Key Laboratory of Drug Regulatory Science, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, P. R. China., Du J; National Institutes for Food and Drug Control, State Key Laboratory of Drug Regulatory Science, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, P. R. China., Xu G; National Institutes for Food and Drug Control, State Key Laboratory of Drug Regulatory Science, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, P. R. China., Li M; National Institutes for Food and Drug Control, State Key Laboratory of Drug Regulatory Science, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, P. R. China., Yu C; National Institutes for Food and Drug Control, State Key Laboratory of Drug Regulatory Science, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, P. R. China.
Publikováno v:
Electrophoresis [Electrophoresis] 2024 Oct; Vol. 45 (19-20), pp. 1665-1672. Date of Electronic Publication: 2024 Jul 08.